Supplemental material
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients
Source:
Elsevier BV
Imaging of normal lung, liver and parotid gland function for radiotherapy
Source:
Informa UK Limited
Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours
Source:
Informa UK Limited
Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Source:
Elsevier BV
Hepatic Galactose Metabolism Quantified in Humans Using 2-18F-Fluoro-2-Deoxy-D-Galactose PET/CT
Source:
Society of Nuclear Medicine
Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography
Source:
American Physiological Society
2-[ 18 F]fluoro-2-deoxy- d -galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours
Source:
Elsevier BV
Phase II study on stereotactic body radiotherapy of colorectal metastases
Source:
Informa UK Limited
Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET
Source:
Elsevier BV
Stereotactic body radiotherapy for oligometastases
Source:
Elsevier BV
Prediction of Liver Function by Using Magnetic Resonance-based Portal Venous Perfusion Imaging
Source:
Elsevier BV
BIGART 2019 – adapting to the future
Source:
Informa UK Limited
Hepatocellular carcinoma
Source:
Elsevier BV
Improved Long-Term Outcome of Surgery for Advanced Colorectal Liver Metastases: Reasons and Implications for Management on the Basis of a Severity Score
Source:
Springer Nature
Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study
Source:
Informa UK Limited
A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[18F]fluoro-2-deoxy-d-galactose
Source:
Taylor & Francis
Normal Liver Tissue Density Dose Response in Patients Treated With Stereotactic Body Radiation Therapy for Liver Metastases
Source:
Elsevier BV
Role of Functional Imaging in Treatment Plan Optimization of Stereotactic Body Radiation Therapy for Liver Cancer
Source:
SAGE Publications
Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer
Source:
Elsevier BV
Analysis of radiation-induced liver disease using the Lyman NTCP model
Source:
Elsevier BV
Hepatocellular Carcinoma: The Role of Interventional Oncology
Source:
S. Karger AG
Adaptive Dose Painting by Numbers for Head-and-Neck Cancer
Source:
Elsevier BV
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality
Source:
Elsevier BV
Clinical implications of advances in liver regeneration
Source:
The Korean Association for the Study of the Liver
Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases
Source:
Elsevier BV
A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[18F]fluoro-2-deoxy-d-galactose
Source:
Taylor & Francis
Linking provided by
